resistell
Resistell develops a diagnostic platform for ultra-rapid phenotypic Antibiotic Susceptibility Testing (AST) using nanomotion technology. The system measures the nanoscale vibrations of living bacterial cells to determine effective antibiotic treatments in approximately one hour, bypassing the need for traditional culture-based growth. The technology is designed for healthcare providers and clinical laboratories to combat antimicrobial resistance and optimize patient therapy.
Healthtech
Diagnostics
Biotechnology
Medical Devices
Funding summary
- Total raised
- €11.9M
- Funding rounds
- 2
Investors in resistell
Investors on record for resistell. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like resistell?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors